Bildkälla: Stockfoto

Alligator Bioscience: Positive FDA Feedback on CMC - Redeye

Redeye comments on the positive interaction with the FDA about ongoing CMC work for the planned phase III study of mitazalimab in pancreatic cancer.

Redeye comments on the positive interaction with the FDA about ongoing CMC work for the planned phase III study of mitazalimab in pancreatic cancer.
Börsvärldens nyhetsbrev
ANNONSER